Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(36%)
Results Posted
17%(1 trials)

Phase Distribution

Ph not_applicable
7
64%
Ph phase_1
4
36%

Phase Distribution

4

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Active, not recruiting2
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 14 (36.4%)
N/A7 (63.6%)

Trials by Status

active_not_recruiting218%
completed655%
recruiting218%
withdrawn19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11